entity

p300/CBP

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about p300/CBP: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

2Connections
1Hypotheses
1Analyses
2Outgoing
0Incoming
0Experiments
1Debates

No AI portrait yet

Outgoing (2)

TargetRelationTypeStr
Tau K280 acetylationactivatesprocess0.70
tau acetylation at K280activatesprocess0.70

Incoming (0)

SourceRelationTypeStr
No incoming edges

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
p300/CBP-dependent K280 acetylation nucleates pathogenic tau 0.455 neurodegeneration Which specific post-translational modifi

Mentioning Analyses (1)

Scientific analyses that reference this entity

Which specific post-translational modifications create druggable epitopes unique

neurodegeneration | 2026-04-10 | 0 hypotheses

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (1)

Multi-agent debates referencing this entity

The debate was structured around this question but no literature was provided to

closed · Rounds: 4 · Score: 0.30 · 2026-04-21

Related Research

Hypotheses and analyses mentioning p300/CBP in their description or question text

No additional research found